De-novo and acquired resistance to immune checkpoint targeting

Nicholas Syn; Michele W.L. Teng; Tony Mok; Ross A. Soo

doi:10.1016/s1470-2045(17)30607-1

De-novo and acquired resistance to immune checkpoint targeting

Nicholas Syn(National University of Singapore), Michele W.L. Teng(QIMR Berghofer Medical Research Institute), Tony Mok(Chinese University of Hong Kong), Ross A. Soo(National University of Singapore)

The Lancet Oncology

December 1, 2017

10.1016/s1470-2045(17)30607-1

Cited by 729

Abstract

Related Papers

No related papers found

Powered by citation graph analysis